{"id":619,"date":"2014-01-14T18:23:20","date_gmt":"2014-01-14T18:23:20","guid":{"rendered":"http:\/\/www.wi.rwth-aachen.de\/SmartMedCN\/?p=619"},"modified":"2014-01-14T18:23:20","modified_gmt":"2014-01-14T18:23:20","slug":"30-sterile-drug-producers-in-china-fail-to-meet-gmp-deadline","status":"publish","type":"post","link":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/2014\/01\/14\/30-sterile-drug-producers-in-china-fail-to-meet-gmp-deadline\/","title":{"rendered":"30% Sterile Drug Producers in China Fail To Meet GMP Deadline"},"content":{"rendered":"<p><strong>CFDA\u2019s recent statistical data shows that there are only 796 sterile drug producers among 1,319 had passed good manufacturing practices standards by the end of 2013. More than 30% sterile drug producers in China fail to meet GMP deadline, most of which are small-sized and middle-sized manufacturers for they can hardly bear the high transition costs. (Source: PharmAisaNews)<\/strong><\/p>\n<h3>\n\u65b0GMP\u843d\u4e0b\u7b2c\u4e00\u9053\u5e37\u5e55 \u533b\u836f\u884c\u4e1a\u683c\u5c40\u5c06\u6539\u5199<\/h3>\n<p>\u6765\u6e90\uff1a\u8bc1\u5238\u65e5\u62a5<br \/>\n\u6838\u5fc3\u63d0\u793a\uff1a\u867d\u7136\u76ee\u524d\u836f\u4f01\u9762\u4e34\u591a\u91cd\u538b\u529b\uff0c\u56f0\u5883\u4e1b\u751f\uff0c\u4f46\u663e\u7136\u533b\u836f\u884c\u4e1a\u6574\u4f53\u4ecd\u662f\u5904\u4e8e\u201c\u9ec4\u91d1\u5341\u5e74\u201d\uff0c\u8fd9\u662f\u4e00\u4e2a\u4f18\u80dc\u52a3\u6c70\u7684\u8fc7\u7a0b\uff0c\u4efb\u4f55\u884c\u4e1a\u7684\u76db\u5bb4\u90fd\u4e0d\u662f\u884c\u4e1a\u5185\u6240\u6709\u4f01\u4e1a \u7684\u76db\u5bb4\uff0c\u5fc5\u7136\u662f\u5c5e\u4e8e\u6709\u51c6\u5907\uff0c\u6709\u80fd\u529b\u7684\u201c\u5f3a\u8005\u201d\u3002\u867d\u7136\u8d85\u8fc7\u56db\u6210\u65e0\u83cc\u836f\u4f01\u505c\u4ea7\uff0c\u4f46\u662f\u6211\u56fd\u76ee\u524d\u836f\u54c1\u751f\u4ea7\u4f01\u4e1a\u6570\u91cf\u4f17\u591a\uff0c\u836f\u54c1\u751f\u4ea7\u4ea7\u80fd\u8fc7\u5269\u7684\u60c5\u51b5\u6bd4\u8f83\u7a81\u51fa\u3002\u6839\u636e\u56fd\u5bb6 \u98df\u836f\u76d1\u603b\u5c40\u6628\u65e5\u62ab\u9732\u7684\u4fe1\u606f\uff0c\u76ee\u524d\u9996\u6279\u5df2\u901a\u8fc7\u8ba4\u8bc1\u4f01\u4e1a\u751f\u4ea7\u7684\u54c1\u79cd\u8986\u76d6\u300a\u56fd\u5bb6\u57fa\u672c\u836f\u7269\u76ee\u5f55\u300b\uff082012\u5e74\u7248\uff09\u4e2d\u6536\u8f7d\u7684\u5168\u90e8\u65e0\u83cc\u836f\u54c1\uff0c\u5373\u4fbf\u5728\u8fd1\u534a\u6570\u505c\u4ea7\u7684\u60c5\u51b5 \u4e0b\uff0c\u4ecd\u80fd\u591f\u6ee1\u8db3\u5e02\u573a\u4f9b\u5e94\u3002<\/p>\n<p>\u65b0\u7248GMP\u8ba4\u8bc1\uff08\u300a\u836f\u54c1\u751f\u4ea7\u8d28\u91cf\u7ba1\u7406\u89c4\u8303\u300b\uff09\u7ec8\u4e8e\u843d\u4e0b\u7b2c\u4e00\u9053\u5e37\u5e55\uff0c523\u5bb6\u836f\u4f01\u7531\u4e8e\u672a\u80fd\u901a\u8fc7\u8ba4\u8bc1\uff0c\u5168\u90e8\u88ab\u8981\u6c42\u6682\u505c\u751f\u4ea7\u3002<\/p>\n<p>\u4e3a\u4ec0\u4e48\u8fd9500\u591a\u5bb6\u65e0\u83cc\u836f\u4f01\u5b81\u613f\u5192\u7740\u505c\u4ea7\u7684\u98ce\u9669\uff0c\u4e5f\u4e0d\u613f\u6539\u9020\u751f\u4ea7\u7ebf\uff1f<\/p>\n<p>\u9996\u5148\uff0c\u4f01\u4e1a\u5bf9\u65b0\u7248GMP\u8ba4\u8bc1\u7684\u79ef\u6781\u6027\u4e5f\u662f\u5176\u901a\u8fc7\u7387\u4f4e\u7684\u539f\u56e0\u4e4b\u4e00\u3002\u867d\u7136\u56fd\u5bb6\u5728\u63a8\u8fdb\u65b0\u7248GMP\u8ba4\u8bc1\u52bf\u5728\u5fc5\u884c\uff0c\u4f46\u4f01\u4e1a\u53d7\u9650\u4e8e\u81ea\u8eab\u53d1\u5c55\u3001\u5b9e\u529b\u4e0d\u6d4e\uff0c\u4f7f\u5f97\u6bcf\u5bb6\u4f01\u4e1a\u5bf9 \u65b0\u7248GMP\u8ba4\u8bc1\u6001\u5ea6\u4e0d\u4e00\uff0c\u90e8\u5206\u4f01\u4e1a\u4ecd\u62b1\u6709\u6cd5\u4e0d\u8d23\u4f17\u7684\u4fa5\u5e78\u5fc3\u7406\u3002\u4e00\u4e2a\u6708\u524d\uff0c\u67d0\u836f\u4f01\u9ad8\u5c42\u5728\u63a5\u53d7\u7b14\u8005\u91c7\u8bbf\u65f6\u8fd8\u5f88\u6709\u4fe1\u5fc3\u7684\u8ba4\u4e3a\uff0cGMP\u8ba4\u8bc1\u8fdb\u5ea6\u4f4e\u4e8e\u9884\u671f\uff0c\u4e00\u5b9a\u4f1a\u5ef6 \u957f\u8ba4\u8bc1\u7684\u671f\u9650\u30022013\u5e7412\u670830\u65e5\uff0cGMP\u8ba4\u8bc1\u622a\u6b62\u671f\u524d\u591c\uff0c\u67d0\u5bb6\u4e0a\u5e02\u516c\u53f8\u8463\u79d8\u5728\u63a5\u53d7\u672c\u62a5\u91c7\u8bbf\u7684\u65f6\u5019\u8fd8\u4fe1\u8a93\u65e6\u65e6\u5730\u8868\u793a\uff0c\u5c31\u7b97\u4e0d\u901a\u8fc7\u8ba4\u8bc1\uff0c\u4e5f\u4e0d\u610f\u5473\u7740\u505c\u4ea7\u3002\u7136\u800c\uff0c\u4e8b\u5b9e\u662f\u6b8b\u9177\u7684\uff0c\u56fd\u5bb6\u98df\u836f\u76d1\u603b\u5c40\u575a\u6301\u8ba4\u8bc1\u6807\u51c6\u4e0d\u964d\u4f4e\uff0c\u671f\u9650\u4e0d\u653e\u677e\u7684\u539f\u5219\uff0c\u8981\u6c42\u672a\u901a\u8fc7\u8ba4\u8bc1\u7684\u65e0\u83cc\u836f\u4f01\u5fc5\u987b\u505c\u4ea7\uff0c\u5b58\u5728\u4fa5\u5e78\u5fc3\u7406\u7684\u4f01\u4e1a\u6b64\u65f6\u4e0d\u5f97\u4e0d\u8fdb\u5165\u201c\u751f\u6b7b\u5371\u5c40\u201d\u3002<\/p>\n<p>\u5176\u6b21\uff0c\u9ad8\u4f01\u7684\u6539\u9020\u6210\u672c\u4ee4\u4f01\u4e1a\u82e6\u4e0d\u582a\u8a00\u3002\u636e\u4e86\u89e3\uff0c2010\u5e74\u7684\u4fee\u8ba2\u7248GMP\u65b0\u89c4\u4e0e1998\u5e74\u65e7\u7248GMP\u76f8\u6bd4\uff0c\u5bf9\u751f\u4ea7\u4f01\u4e1a\u7684\u751f\u4ea7\u786c\u4ef6\u548c\u8f6f\u4ef6\u6807\u51c6\u5747\u6709\u5927\u5e45\u7684\u63d0 \u5347\uff0c\u662f\u4e00\u4e2a\u4e0e\u56fd\u9645\u63a5\u8f68\u7684\u65b0\u7684\u751f\u4ea7\u6807\u51c6\u3002\u6709\u5a92\u4f53\u66fe\u7ecf\u8ba1\u7b97\u8fc7\uff0c\u6309\u7167\u76ee\u524d\u65b0\u7248\u7684GMP\u6807\u51c6\uff0c\u5efa\u4e00\u6761\u5168\u65b0\u4e59\u809d\u75ab\u82d7\u7684\u751f\u4ea7\u7ebf\u9700\u8981\u82b1\u8d392.5\u4ebf\u5143\uff0c\u8fd9\u4e00\u6570\u5b57\u76f8\u5f53\u4e8e\u4e00\u5bb6 \u4e2d\u578b\u533b\u836f\u4f01\u4e1a\u5168\u5e74\u7684\u5229\u6da6\u603b\u989d\uff0c\u8fd9\u4e5f\u610f\u5473\u7740\uff0c\u4e00\u5bb6\u65e0\u83cc\u836f\u4f01\u6bcf\u5e74\u7684\u5229\u6da6\u53ea\u591f\u5efa\u9020\u4e00\u6761\u751f\u4ea7\u7ebf\u3002<\/p>\n<p>\u5927\u6d6a\u6dd8\u6c99\uff0c\u65b0\u7248GMP\u8ba4\u8bc1\u6210\u4e3a\u8fd9\u4e00\u8f6e\u533b\u836f\u884c\u4e1a\u6d17\u724c\u7684\u5165\u95e8\u5238\u3002<\/p>\n<p>\u4e0a\u4e00\u6b21GMP\u8ba4\u8bc1\u53d1\u751f\u57282004\u5e74\uff0c\u8001\u7248GMP\u8ba4\u8bc1\u4e3b\u8981\u9488\u5bf9\u786c\u4ef6\u65b9\u9762\u7684\u6539\u9020\uff0c\u6309\u7167\u5f53\u65f6\u4f18\u80dc\u52a3\u6c70\u7684\u601d\u8def\uff0c25%\u7684\u5236\u836f\u4f01\u4e1a\u906d\u5230\u6dd8\u6c70\uff0c\u9000\u51fa\u5386\u53f2\u821e\u53f0\u3002\u8fd9\u4e00\u6b21 GMP\u8ba4\u8bc1\u6dd8\u6c70\u7684\u529b\u5ea6\u66f4\u5927\uff0c\u6309\u7167\u76ee\u524d\u901a\u8fc7\u8ba4\u8bc1\u7684\u4f01\u4e1a\u6570\u636e\u6765\u770b\uff0c\u56db\u6210\u5236\u836f\u4f01\u4e1a\u9762\u4e34\u505c\u4ea7\u3001\u88ab\u517c\u5e76\uff0c\u751a\u81f3\u5176\u4e2d\u4e0d\u4e4f\u4e0a\u5e02\u516c\u53f8\u7684\u8eab\u5f71\u3002<\/p>\n<p>\u867d\u7136\u76ee\u524d\u836f\u4f01\u9762\u4e34\u591a\u91cd\u538b\u529b\uff0c\u56f0\u5883\u4e1b\u751f\uff0c\u4f46\u663e\u7136\u533b\u836f\u884c\u4e1a\u6574\u4f53\u4ecd\u662f\u5904\u4e8e\u201c\u9ec4\u91d1\u5341\u5e74\u201d\uff0c\u8fd9\u662f\u4e00\u4e2a\u4f18\u80dc\u52a3\u6c70\u7684\u8fc7\u7a0b\uff0c\u4efb\u4f55\u884c\u4e1a\u7684\u76db\u5bb4\u90fd\u4e0d\u662f\u884c\u4e1a\u5185\u6240\u6709\u4f01\u4e1a\u7684\u76db\u5bb4\uff0c\u5fc5 \u7136\u662f\u5c5e\u4e8e\u6709\u51c6\u5907\uff0c\u6709\u80fd\u529b\u7684\u201c\u5f3a\u8005\u201d\u3002\u867d\u7136\u8d85\u8fc7\u56db\u6210\u65e0\u83cc\u836f\u4f01\u505c\u4ea7\uff0c\u4f46\u662f\u6211\u56fd\u76ee\u524d\u836f\u54c1\u751f\u4ea7\u4f01\u4e1a\u6570\u91cf\u4f17\u591a\uff0c\u836f\u54c1\u751f\u4ea7\u4ea7\u80fd\u8fc7\u5269\u7684\u60c5\u51b5\u6bd4\u8f83\u7a81\u51fa\u3002\u6839\u636e\u56fd\u5bb6\u98df\u836f\u76d1\u603b\u5c40 \u6628\u65e5\u62ab\u9732\u7684\u4fe1\u606f\uff0c\u76ee\u524d\u9996\u6279\u5df2\u901a\u8fc7\u8ba4\u8bc1\u4f01\u4e1a\u751f\u4ea7\u7684\u54c1\u79cd\u8986\u76d6\u300a\u56fd\u5bb6\u57fa\u672c\u836f\u7269\u76ee\u5f55\u300b\uff082012\u5e74\u7248\uff09\u4e2d\u6536\u8f7d\u7684\u5168\u90e8\u65e0\u83cc\u836f\u54c1\uff0c\u5373\u4fbf\u5728\u8fd1\u534a\u6570\u505c\u4ea7\u7684\u60c5\u51b5\u4e0b\uff0c\u4ecd\u80fd\u591f\u6ee1 \u8db3\u5e02\u573a\u4f9b\u5e94\u3002<\/p>\n<p>\u533b\u836f\u884c\u4e1a\u6d17\u724c\u5df2\u7ecf\u6765\u4e34\uff0c\u4ecd\u7136\u5b58\u5728\u4fa5\u5e78\u5fc3\u7406\u4f01\u56fe\u8499\u6df7\u8fc7\u5173\u7684\u836f\u4f01\uff0c\u6216\u5c06\u6210\u4e3a\u88ab\u517c\u5e76\u7684\u5bf9\u8c61\uff0c\u672a\u6765\u7684\u533b\u836f\u5e02\u573a\u683c\u5c40\u5c06\u56e0\u6b64\u6539\u5199\u3002\uff08\u80e1\u6f47\u6ee2\uff09<\/p>\n","protected":false},"excerpt":{"rendered":"<p>CFDA\u2019s recent statistical data shows that there are only 796 sterile drug producers among 1,319 had passed good manufacturing practices standards by the end of 2013. More than 30% sterile [&hellip;]<\/p>\n","protected":false},"author":951,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"c2c_always_allow_admin_comments":false,"footnotes":""},"categories":[2,5],"tags":[13,22,28],"class_list":["post-619","post","type-post","status-publish","format-standard","hentry","category-government-news","category-pharmaceutical-company-news","tag-drug-saftey","tag-legislation","tag-standards"],"_links":{"self":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/users\/951"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/comments?post=619"}],"version-history":[{"count":0,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/posts\/619\/revisions"}],"wp:attachment":[{"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/media?parent=619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/categories?post=619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.rwth-aachen.de\/smartmedcn\/wp-json\/wp\/v2\/tags?post=619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}